drawbacks of glp 1 GLP-1 weight loss medications have significant side effects Pros & cons of GLP-1

Novo Nordisk, Eli Lilly, Pfizer, Amgen and others are all competing to develop stronger and more convenient weight loss drugs

Recent advancementsincluding the approval of oral semaglutide (Rybelsus)have demonstrated the potential for effective oral peptide delivery, though such formulations still face significant pharmacokinetic and formulation-related challenges

Unlike semaglutide, which focuses primarily on GLP-1 receptor activation to manage blood sugar and appetite, Personalized GLP-1targets additional metabolic pathways for a more comprehensive weight management solution

The answer, in our new @BMJMedicine, is more interesting than yes or no

Medical Weight Loss Program -